Recent Updates
Recently added Catalysts
BIIB

Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research

Key Takeaway: Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis

Full Press Release Details

Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research.
Last updated: Jan 9, 2015